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Background: Reduced chronotropic response to maximal exercise has been associated with
poor survival in people without respiratory disease. The contribution of chronotropic response
to exercise limitation and survival in interstitial lung disease (ILD) is not well defined. This
study investigated the relationships between chronotropic response during 6-min walk test, ex-
ercise capacity and survival in ILD.
Methods: Eligible participants had ILD, were ambulant and free of heart failure and beta
blocker therapy. Chronotropic response during the 6-min walk test was defined as peak heart
rate (HR) minus resting HR. Survival was recorded at four years.
Results: Sixty-two participants (40 idiopathic pulmonary fibrosis) were included, with mean
(SD) TLCO 50(18)% predicted and 6-min walk distance (6MWD) 377 (127) metres. A smaller
chronotropic response was associated with reduced 6MWD (rZ 0.65, p < 0.001). Independent
predictors of 6MWD were chronotropic response, peak oxygen uptake on cardiopulmonary ex-
ercise test; right ventricular systolic pressure on echocardiogram; and age. This model ex-
plained 83% of the variance in 6MWD, with 24% of the variance attributable to chronotropic
response. A chronotropic response during 6-min walk test of less than 20 beats per minute
was an independent predictor of death at four years (odds ratio 10.71, 95% confidence interval
2.67e42.94) in a model that also included oxygen desaturation and forced vital capacity.
Conclusions: Impaired chronotropic response to 6-min walk test is associated with reduced
6MWD and reduced survival in ILD, independent of physical fitness and pulmonaryiversity, Physiotherapy, VIC 3086, Australia. Tel.: þ61 3 94796744; fax: þ61 3 95332104.
org.au (A.E. Holland).
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Chronotropic response to exercise in ILD 1067hypertension. Investigation of the mechanisms underlying attenuated HR response to exercise
in ILD is warranted.
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Exercise intolerance is a cardinal feature of the interstitial
lung diseases (ILDs). Reduced exercise capacity is associ-
ated with significant exertional dyspnoea, fatigue and poor
quality of life.1,2 Exercise performance is a strong predictor
of prognosis, with increased mortality associated with
lower peak oxygen capacity, shorter 6-min walk distance
(6MWD) and greater exercise-induced hypoxaemia.3e5 The
mechanisms of exercise intolerance are not fully under-
stood, but include altered ventilatory mechanics, impaired
gas exchange, peripheral muscle dysfunction and circula-
tory dysfunction.6 The relative contribution of these factors
to exercise performance and survival has not been
established.
An increase in heart rate during exercise is a crucial
contributor to aerobic exercise capacity in healthy in-
dividuals.7 The heart rate response to exercise reflects the
integrated response of many physiologic processes related
to age, physical fitness, resting heart rate, coronary artery
disease, autonomic nervous system function and use of
medications.8 Chronotropic incompetence occurs when an
individual does not achieve 80% of heart rate reserve,
calculated as the change in heart rate (HR) from rest to
peak exercise on a maximum symptom-limited exercise
test.9 Chronotropic incompetence predicts all-cause and
cardiovascular mortality in large studies of apparently
healthy men.10,11 The association between chronotropic
incompetence and mortality is independent of physical
fitness,12 coronary artery disease13 and myocardial
perfusion.14
The contribution of chronotropic response to exercise
limitation in ILD is not well defined. The current definition
of chronotropic incompetence may not be applicable in this
group, where ventilatory limitation frequently limits
maximal exercise performance6 and may reduce the
maximal heart rate that can be achieved.15 Recent studies
have examined HR responses to submaximal exercise,
showing that heart rate recovery following a 6-min walk
test predicts survival in patients with idiopathic pulmonary
fibrosis,16,17 however the relevance of HR responses during
exercise was not evaluated. In pulmonary arterial hyper-
tension, chronotropic response to 6-min walk test (degree
of change in HR during exercise) predicts 6MWD, indepen-
dently of stroke volume.18 It is not known whether chro-
notropic response to 6MWD is useful to predict exercise
capacity or survival in ILD.
The aims of this study were to (1) evaluate the contri-
bution of chronotropic response to functional exercise ca-
pacity in ILD; (2) assess the relationship of chronotropic
response to mortality; and (3) compare indices of chrono-
tropic response obtained from maximal and sub-maximal
exercise testing in ILD. We hypothesised that impaired
chronotropic response would be associated with reducedfunctional exercise capacity, independent of physical
fitness; impaired chronotropic response would be associ-
ated with poorer survival; and chronotropic response
measured on 6-min walk test was a more sensitive marker
of survival than chronotropic incompetence measured on a
cardiopulmonary exercise test.
Methods
Patients with documented ILD were recruited from two
tertiary hospitals for two investigator-initiated studies
examining exercise responses in ILD.19,20 All participants
gave written informed consent and the study was approved
by the human ethics committees at both sites (210/04, 15/
07). Diagnostic criteria for IPF were consistent with the
International Consensus Statement.21 For this study, par-
ticipants were excluded if they were non-ambulant, had co-
existent heart failure, were currently taking beta-blockers
or digitalis, reported a history of syncope on exertion or
had any comorbidities precluding exercise testing.
Functional exercise capacity was assessed using the 6-
min walk test (6MWT).22 Two tests were performed, with
the best distance used for analysis. Use of oxygen during
the test was standardised.23 Participants were permitted to
stop during the test if their symptoms became intolerable,
but were encouraged to resume walking as soon as possible.
Borg dyspnoea scores were recorded at the end of the
test.24 Heart rate and oxygen saturation were recorded
continuously during the test using a pulse oximeter (Palm-
SAT 2055; Nonin Medical, Plymouth, MN, USA). Chronotropic
response was defined as peak HR minus resting HR.18 In 54
participants an incremental exercise test (IET) was per-
formed on a cycle ergometer.25 Chronotropic incompetence
was defined as failure to achieve 80% of heart rate reserve
during the incremental test.7 Measurements of spirometry,
diffusing capacity and plethysmographic lung volumes were
obtained and a trans-thoracic echocardiogram was
performed.
Participants were followed for a minimum of four years,
with vital status ascertained on 11th May 2009 by medical
record review or individual patient follow up as required.
Survival time was calculated as the time of the 6MWT to the
time of death or censoring.
The relationship of demographic and clinical variables,
including chronotropic response, to 6MWD was assessed
using multiple regression analysis. Prior to developing the
model we assessed univariate relationships between 6MWD
and possible predictors, which included demographic vari-
ables (age, BMI, IPF diagnosis yes/no); resting physiology
(FVC, TLCO, RVSP, resting HR); and exercise responses from
the 6-min walk test and IET. Exercise variables evaluated
were chronotropic response, maximum HR and end-walk
Borg score on 6-min walk test; VO2 peak and peak ventila-
tion (VEpeak) on IET; and peak oxygen pulse (VO2 peak/
Table 1 Demographic characteristics of participants.
All
participants
IPF Other
ILD
p
Value
Age, years 71 (11) 73 (7) 66 (14) 0.02
BMI, kg m2 29 (5) 30 (5) 27 (5) 0.06
FVC % pred 77 (22) 74 (20) 82 (25) 0.19
TLCO % pred 50 (18) 46 (17) 56 (17) 0.05
RVSP, mmHg 37 (13) 39 (15) 33 (9) 0.22
6MWD, metres 378 (127) 350 (124) 424 (121) 0.03
Nadir SpO2, % 87 (7) 86(8) 90 (5) 0.04
HR at rest, bpm 79 (14) 80 (14) 78 (12) 0.55
HR maximum on
6MWT, bpm
107 (16) 106 (17) 108 (16) 0.72
Chronotropic
response, bpm
28 (13) 26 (12) 30 (14) 0.26
VO2 peak
% predicted
57 (18) 57 (19) 58 (16) 0.74
Data are mean (standard deviation). P values are comparison of
IPF and non-IPF participants. BMI e body mass index; bpm e
beats per minute; FVC e forced vital capacity; TLCO e diffusing
capacity for carbon monoxide; RVSP e right ventricular systolic
pressure measured on echocardiography; 6MWD e 6-min walk
distance; SpO2 e oxyhaemoglobin saturation during 6-min walk
test; HR e heart rate; VO2 peak e peak oxygen uptake
measured on cardiopulmonary exercise test.
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with p < 0.1 on univariate testing were included in the
multivariate model and the forward conditional method
was used to determine independent predictors of 6MWD. An
a priori decision was made to include VO2 peak in the
model, to assess the contribution of chronotropic response
to 6MWD whilst controlling for physical fitness.
Differences in chronotropic response on 6-min walk test
between survivors and non-survivors at four years were
evaluated with the Mann Whitney U test. The performance
of chronotropic response in predicting survival was assessed
using receiver operating characteristic (ROC) curves. The
effect of impaired chronotropic response on survival time
was evaluated using Kaplan Meier survival curves and
groups were compared using the log rank test.10 The impact
of impaired chronotropic response and other clinical vari-
ables on survival at four years was assessed using logistic
regression analysis. Prior to developing the model we
assessed univariate relationships between survival and
markers of disease severity and survival, as described in the
6MWD analyses above. Variables with a univariate rela-
tionship to survival (p < 0.1) were included in the model.
Forced vital capacity was also included in the model, to
assess the performance of chronotropic response as a pre-
dictor of survival when compared to a more established
marker. The Hosmer and Lemeshow test was used to eval-
uate model fit. We performed a sensitivity analysis by
excluding those who stopped during the 6-min walk test, to
assess the effects of test cessation on the relationship be-
tween chronotropic response and study outcomes (6MWD
and survival). The analysis of chronotropic response was
repeated using heart rate data obtained from the ECG on
IET, to assess the accuracy of this model compared to that
obtained using heart rate data from the 6-min walk test.
Statistical significance was determined by a p value of
<0.05. All analyses were undertaken using SPSS version
19.0 (SPSS Inc; Chicago, IL).Figure 1 Relationship between chronotropic response and 6-
min walk distance.Results
Sixty-two participants with ILD (32 males) were recruited.
Forty participants (65%) had a confident diagnosis of IPF,
whilst other participants had diagnoses of connective tissue
related ILD (n Z 9), dust-related ILD (n Z 4), granuloma-
tous ILD (nZ 4), drug-related ILD (nZ 2), hypersensitivity
pneumonitis (n Z 2) and Langerhans cell histiocytosis
(n Z 1). Forced vital capacity ranged from 32 to 102%
predicted and the 6MWD ranged from 49 to 681 m (Table 1).
Eight participants stopped at least once during the 6-min
walk test. Participants with IPF had more severe impair-
ment of TLCO and 6MWD than those with other ILDs, but did
not differ for right ventricular systolic pressure (RVSP), HR
response to exercise or VO2 peak. On the IET, 39 of 54
participants (72%) failed to achieve 80% of their HR reserve
and were designated as chronotropically incompetent.
The mean increase in HR during the 6-min walk test was
28 beats per minute (bpm), with a range of 5e55 bpm. A
smaller chronotropic response was associated with a
shorter 6MWD (r Z 0.65, p < 0.001, Fig. 1). A significant
relationship was also observed between 6MWD and peak HR
(r Z 0.41, p Z 0.001) but not resting HR (r Z 0.11,p Z 0.40). There was no relationship between 6MWD and
Borg scores at the end of the test (rSZ 0.16, pZ 0.27). As
expected, a lower VO2 peak on IET was also associated with
a lower 6MWD (r Z 0.72, p < 0.01). In the stepwise
regression analysis, independent predictors of 6MWD were
VO2 peak, chronotropic response, age and RVSP on echo-
cardiogram. This indicates that lower physical fitness, a
smaller HR response during the walk test, older age and a
greater degree of pulmonary hypertension were indepen-
dently associated with a lower 6MWD. This model explained
83% of the variance in 6MWD, with 24% of the variance
attributable to chronotropic response (Table 2). When
those who stopped during the 6MWT were excluded from
the analysis, there was no change in the predictors of 6MWD
(model not shown).
Table 2 Predictors of 6-min walk distance on stepwise multiple regression analysis.
Variable B SE Standardised beta p Value R2 change
VO2 peak, ml kg min
1 14.39 2.63 0.43 <0.001 0.51
Chronotropic response, bpm 3.64 0.77 0.36 <0.001 0.24
Age, years 3.34 0.90 0.28 0.001 0.05
RVSP, mmHg 2.05 0.76 0.21 0.10 0.03
Constant 390.34 105.78 0.001
R2 0.83
VO2 peak e peak oxygen uptake on incremental cycle ergometer test; bpm e beats per minute; RVSP e right ventricular systolic pressure
on transthoracic echocardiogram; B e unstandardised coefficient; SE e standard error of the coefficient; R2 e proportion of observed
variance in 6-min walk distance explained by the model.
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had IPF. The median chronotropic response to 6-min walk
test in those who survived at four years was 30 bpm,
compared to 16 bpm in non-survivors (p < 0.001). The ROC
curve identified a chronotropic response of 20 bpm as the
best threshold for predicting death at four years, with a
sensitivity of 0.85 and specificity of 0.70. When only those
with IPF were included, the thresholds for sensitivity and
specificity were 0.67 and 0.92 respectively. Kaplan Meier
survival curves comparing those with chronotropic response
of 20 bpm to those with chronotropic response > 20 bpm
are shown in Fig. 2 (log rank test p < 0.001 for difference
between groups).Figure 2 Kaplan Meier survival curves for those with a
chronotropic response 20 bpm compared to those with
chronotropic response >20 bpm.
Table 3 Predictors of four year survival in interstitial lung dise
Estimate SE
Impaired chronotropic
response to 6-min
walk test
2.37 0.71
Nadir SpO2 on 6-min
walk test
0.10 0.05
FVC 0.42 0.44
Constant 7.97 4.43
SpO2 e oxyhaempoglobin saturation; 6MWT e 6-min walk test; FVC e
terval.Forty-one percent of those who were assessed as chro-
notropically incompetent on the IET using standard criteria7
were deceased at four years, whilst all of those who did not
have chronotropic incompetence were still alive
(p Z 0.002). Chronotropic incompetence on IET was
therefore highly sensitive for predicting survival
(sensitivityZ 1.0), however specificity was 0.39. When only
those with IPF were included, sensitivity and specificity
were 1.0 and 0.5 respectively.
Variables associated with survival at four years were
impaired chronotropic response to 6-min walk test
(p < 0.001), RVSP (p Z 0.001), nadir SpO2 on 6MWT
(p Z 0.006), 6MWD (p Z 0.011) and FVC (p Z 0.012). A
diagnosis of IPF was not significantly associated with sur-
vival (p Z 0.23). The final model is shown in Table 3. The
Hosmer and Lemeshow test indicated good model fit
(c2 Z 10.41, p Z 0.24). Impaired chronotropic response
was an independent predictor of survival; those with a
chronotropic response of 20 bpm on 6MWTwere almost 11
times more likely to have died at four years. When those
who stopped during the 6MWT were excluded from the
analysis (n Z 8), there was no change in the predictors of
survival; those with impaired chronotropic response were
almost 10 times more likely to have died at four years
(model not shown).
When the analysis was repeated using heart rate (ECG)
and SpO2 data from the IET, there was little change in the
model. Chronotropic response remained an independent
predictor of survival and those with impaired response were
almost 10 times more likely to have died at four years
(Table 4). The ROC curve identified a chronotropic response
on IET of 40 bpm as the best threshold for predictingase using 6-min walk test.
p Value Odds ratio 95% CI
0.001 10.71 2.67e42.94
0.058 0.91 0.82e1.003
0.35 0.66 0.28e1.57
0.07
forced vital capacity; SE e standard error; CI e confidence in-
Table 4 Predictors of four year survival in interstitial lung disease using incremental exercise test.
Estimate SE p Value Odds ratio 95% CI
Impaired chronotropic response to IET 2.29 0.76 0.003 9.85 2.21e43.90
Nadir SpO2 on IET 0.01 0.05 0.83 0.99 0.89e1.10
FVC 0.52 0.46 0.26 0.60 0.24e1.49
Constant 0.16 4.61 0.97
IET e incremental exercise test; SpO2 e oxyhaempoglobin saturation; 6MWT e 6-min walk test; FVC e forced vital capacity; SE e
standard error; CI e confidence interval.
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of 0.81.Discussion
This study has shown that in individuals with ILD, a smaller
chronotropic response to 6-min walk test is associated with
lower functional exercise capacity and reduced survival at
four years. These effects were independent of physical
fitness and the usual markers of disease severity. A chro-
notropic response of 20 bpm on 6-min walk test identified
a high risk patient group with adequate sensitivity and
specificity.
In healthy individuals, the increase in HR during exercise
is the largest contributor to aerobic exercise performance,
having a larger role than stroke volume or oxygen extrac-
tion.26 Our study has shown that chronotropic response is
an independent contributor to 6MWD in ILD, suggesting that
HR response has a similarly important role during submax-
imal exercise capacity in this patient group. Our model
explained 83% of the observed variation in 6MWD, with 24%
of the variance attributable to chronotropic response
(Table 2). Whilst peak HR also showed a strong relationship
to 6MWD, the same relationship was not evident for resting
HR, indicating that it is the failure to increase HR during
exertion that impacts on exercise capacity, rather than an
elevation in the resting heart rate. These results confirm
previous observations in IPF15,17 and PAH,18 where smaller
elevations in heart rate during submaximal and maximal
exercise testing have been associated with lower exercise
capacity. Our work extends these observations by con-
firming that this relationship is independent of measured
VO2 peak and age, indicating that reduced chronotropic
response is not simply a function of lower physical fitness
and age-related changes in heart rate.7 The 6MWD has
prognostic significance in ILD,4 so the large proportion of
variance in this measure that is explained by the chrono-
tropic response further supports the significance of an
inadequate HR increase during exercise in this population.
Failure to increase HR more than 20 bpm during the 6-
min walk test was a strong predictor of survival at four
years. The relationship between impaired heart rate
response and poor outcome is well established in the car-
diovascular literature.11,12 Few studies have investigated
the prognostic importance of heart rate changes during
exercise in ILD, perhaps because of the predominance of
ventilatory and circulatory limitations to exercise in this
group. In IPF, previous authors have shown that abnormal
heart rate recovery at 1 min and 2 min after a 6-min walktest was associated with reduced survival.16 These authors
also showed that a smaller chronotropic response was
associated with a slower heart rate recovery, however its
relationship to survival was not investigated. Predictors of
survival are important for informing clinical care and as
endpoints in clinical trials.27 In this cohort, a chronotropic
response to 6-min walk test of 20 bpm performed well as a
predictor of survival when compared to FVC, a commonly
used surrogate for survival in ILD (Table 3). The relative
utility of chronotropic response compared to other pre-
dictors of survival, including FVC and heart rate recovery,
should be evaluated in future studies.
Chronotropic incompetence, as defined by failure to
achieve a set percentage of the age-predicted maximum
heart rate, requires an incremental exercise test for
definitive diagnosis.7 However in this study, 72% of partic-
ipants were defined as chronotropically incompetent,
which reduced the specificity of the test in predicting sur-
vival. The chronotropic response calculated from ECG data
on IET proved to be a useful marker of survival, but pro-
vided no more information than if it was calculated from
the 6-min walk test. In IPF, the role of laboratory-based,
incremental exercise testing is not well defined and it is
not recommended for routine monitoring.28 In contrast, 6-
min walk tests are routinely performed to monitor func-
tional status and oxygenation in people with ILD. Our study
suggests that evaluation of heart rate responses during a
6MWT is both feasible and meaningful in this population.
Our data reinforce the need for new ways to assess the
contribution of heart rate to exercise performance in in-
dividuals with respiratory and circulatory limitations to
exercise.
The mechanisms responsible for reduced chronotropic
response in our sample are not known. Data from other
groups with chronic disease suggests a contribution from
chronically elevated sympathetic nervous system activity
and resulting downregulation of b-adrenergic receptors.
Increased sympathetic nervous system activation has been
demonstrated in pulmonary arterial hypertension, where it
is associated with increased heart rate and reduced
6MWD.29 Sympathetic nervous system activation was a
better predictor of clinical deterioration than HR or 6MWD.
In people with heart failure, where circulating catechol-
amines are known to be chronically elevated, a lower
density of endomyocardial b-adrenergic receptors was
associated with impaired chronotropic response and
reduced VO2 peak.
30 Preliminary data indicate increased
sympathetic activation in a small group of patients with
lung fibrosis and chronic hypoxaemia.31 The authors
postulated that alterations in the chemoreceptor activation
Chronotropic response to exercise in ILD 1071of sympathetic outflow may play a role, however other
mechanisms, such as the impact of elevated pulmonary
pressures on the myocardium, could also contribute.
If the reduction in chronotropic response to exercise in
ILD is common and clinically significant, as suggested by our
results, new treatment strategies should be considered. In
heart failure, endurance exercise training has been shown
to reduce sympathetic outflow and circulating catechol-
amines.32 This is associated with an increase in peak heart
rate.33 However, preliminary data on a combination of
endurance and strength training in ILD do not suggest any
effect on peak HR.19 Whether other training modes might
prove more effective in addressing chronotropic response in
ILD is not known. The impact of treating hypoxaemia or
pulmonary hypertension on autonomic function and heart
rate responses in ILD should also be studied.
This study has a number of limitations, including a
modest sample size and inclusion of participants with a
variety of ILDs. These results need to be validated in a
larger sample, where potential for differing effects in
diagnostic groups can be more clearly delineated. We were
not able to determine the exact cause of death for our
participants, so we cannot specify how many deaths were
due to cardiac or respiratory causes. However, a recent
suggests that all-cause mortality is the most relevant
endpoint in IPF trials, as it retains all clinically relevant
information.27 Due to the extended time period required to
collect information about mortality, our participants were
recruited some years ago, when different diagnostic
criteria were used21 compared to those in use today.28 It is
possible that the use of modern diagnostic criteria might
have affected our subgroup analyses; however the consis-
tent relationship between chronotropic response and sur-
vival in this study, regardless of diagnosis, suggests that any
effect would be small. Our heart rate data during the 6-min
walk test were obtained by pulse oximetry rather than
electrocardiogram (ECG), which may have increased the
error associated with this measure. However, previous au-
thors have reported that heart rate obtained from a pulse
oximeter during exercise is highly accurate when compared
to ECG at heart rates up to 155 bpm.34 The maximum heart
rate recorded during the 6-min walk test in this study was
149 bpm, suggesting that accurate heart rate data were
obtained. Use of a pulse oximeter to record heart rate
during a walk test reflects usual clinical practice and
chronotropic response collected in this manner proved to
be a sensitive predictor of outcome.
In conclusion, a reduced chronotropic response during
the 6MWT is associated with reduced exercise tolerance
and increased mortality in ILD. Failure of the HR to rise
more than 20 bpm during a 6MWT may be a simple predictor
of outcome. Future studies should investigate the mecha-
nism of reduced HR response and whether it can be modi-
fied by emerging treatments.Conflict of interest statement
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